For: |
Liu J, Zhu LX, Kong YY, Li GD, Wang Y. Purification and application of C-terminally truncated hepatitis C virus E1 proteins expressed in |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i4/503.htm |
Number | Citing Articles |
1 |
Giuseppe Sautto, Alexander W. Tarr, Nicasio Mancini, Massimo Clementi. Structural and Antigenic Definition of Hepatitis C Virus E2 Glycoprotein Epitopes Targeted by Monoclonal Antibodies. Clinical and Developmental Immunology 2013; 2013: 1 doi: 10.1155/2013/450963
|
2 |
Zhong-Hua Xiang, Wei-Jia Cai, Peng Zhao, Ling-Bao Kong, Lin-Bai Ye, Zheng-Hui Wu. Purification and application of bacterially expressed chimeric protein E1E2 of hepatitis C virus. Protein Expression and Purification 2006; 49(1): 95 doi: 10.1016/j.pep.2006.02.013
|
3 |
Heba Shawky, Ashraf A. Tabll, Reem M. Elshenawy, Naiera M. Helmy, Rehab I. Moustafa, Yasser K. Elesnawy, Marwa M. Abdelghany, Yasmine S. El-Abd. Glycylglycine promotes the solubility and antigenic utility of recombinant HCV structural proteins in a point-of-care immunoassay for detection of active viremia. Microbial Cell Factories 2024; 23(1) doi: 10.1186/s12934-024-02297-1
|
4 |
Siobhán B. Cashman, Brian D. Marsden, Lynn B. Dustin. The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development. Frontiers in Immunology 2014; 5 doi: 10.3389/fimmu.2014.00550
|
5 |
Sadia Butt, Muhammad Idrees, Irshad-ur Rehman, Liaqat Ali, Abrar Hussain, Muhammad Ali, Naveed Ahmed, Sana Saleem, Madiha Fayyaz. Establishment of stable Huh-7 cell lines expressing various hepatitis C virus genotype 3a protein: an in-vitro testing system for novel anti-HCV drugs. Genetic Vaccines and Therapy 2011; 9(1) doi: 10.1186/1479-0556-9-12
|